a single-blind crossover trial in 60 patients with rheumatoid arthritis showed that piroxicam , 20 mg daily and naproxen , 500 mg twice daily were comparable in both efficacy and tolerance .
C0003873
rheumatoid arthritis
C0027396
naproxen